Preoperative predictors of occult metastases in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma

Preoperative predictors of occult metastases in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma - Predictors of occult metastases in R and BR PDAC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049693

Enrollment

270

Registered

2022-12-05

Start date

2021-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic ductal adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who were planned for radical pancreatectomy at Sapporo Medical University 2) Pathologically or cytologically proven diagnosis of PDAC 3) Patients with R and BR PDAC

Exclusion criteria

Exclusion criteria: 1) Patients who underwent staging laparoscopy because of ascites or nodules suspected of peritoneal dissemination on MDCT 2) Patients with CA19-9 levels < 2 U/mL 3) Patients with < 6 months of follow-up despite the absence of OM

Design outcomes

Primary

Measure	Time frame
Significant predictors of OM	—

Secondary

Measure	Time frame
Prognostic analysis by presence or absence of OM Diagnostic accuracy of OM by predictors	—

Countries

Japan

Contacts

Public ContactTakeshi Murakami

Sapporo Medical University Department of Surgery, Surgical Oncology and Science

murakami.takeshi@sapmed.ac.jp0116112111

Outcome results